Kensey Nash embolic filter:
This article was originally published in Clinica
Kensey Nash has CE-marked for sale in Europe a third-generation version of its TriActiv system for preventing debris that has become dislodged during stenting from embolising downstream and causing adverse coronary events. The TriActiv ProGuard product is set to be launched for use in saphenous vein graft procedures by the end of March 2006. It incorporates several design enhancements compared with the earlier TriActiv platform, including a Local Flush and eXtraction technology that allows the system to better address branched anatomy and a smaller 6F compatible size, which is generally preferred by physicians, particularly in Europe, said the Exton, Pennsylvania firm.